Biolife Solutions (BLFS) Accumulated Depreciation & Amortization (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Accumulated Depreciation & Amortization data on file, last reported at $374000.0 in Q1 2026.

• Quarterly Accumulated Depreciation & Amortization fell 45.16% year-over-year to $374000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $374000.0 (down 45.16% YoY) and the FY2025 annual result came in at $2.3 million, down 56.34% from the prior year.
• Accumulated Depreciation & Amortization declined to $374000.0 in Q1 2026 per BLFS's latest filing, from $2.3 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $7.1 million in Q1 2022 and bottomed at $374000.0 in Q1 2026.
• The 5-year median for Accumulated Depreciation & Amortization is $3.3 million (2022), against an average of $3.6 million.
• The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 61.55%; it then slumped 75.88% in 2023.
• Tracing BLFS's Accumulated Depreciation & Amortization over 5 years: stood at $6.8 million in 2022, then rose by 5.0% to $7.1 million in 2023, then declined by 27.47% to $5.2 million in 2024, then plunged by 56.34% to $2.3 million in 2025, then sank by 83.4% to $374000.0 in 2026.
• Per Business Quant, the three latest BLFS Accumulated Depreciation & Amortization figures stand at $374000.0 (Q1 2026), $2.3 million (Q4 2025), and $2.0 million (Q3 2025).

Peer Comparison